Dr. Mark Alan Scheperle, MD

  • Saint Louis, MO
  • Internist
NPI1265417034PAC ID0244238020
Medicare services, 2024
804
Medicare patients, 2024
250
Part D claims, 2024
10,174
MIPS score, 2024
79
Hospital affiliations
6
Practice address
3960 Lindell Blvd, Saint Louis, MO 63108
Practice phone
Call (314) 652-0100
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Novus Health Inc

Saint Louis, Missouri

See all 11 affiliations

Find Dr. Scheperle's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark Alan Scheperle is an internist in Saint Louis, Missouri

Dr. Scheperle practices at Novus Health Inc in Saint Louis, Missouri.

Dr. Scheperle's NPI, 1265417034, was assigned on December 14, 2005. Dr. Scheperle graduated from UMKC School of Medicine in 1989. Dr. Scheperle holds Missouri license R8N98.

NPI and contact details
Medicare PAC ID
0244238020
NPI enumeration date
December 14, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(314) 652-0100
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark Alan Scheperle practices at Novus Health Inc in Saint Louis, Missouri

Dr. Scheperle's primary practice is Novus Health Inc, at 3960 Lindell Blvd, Saint Louis, MO 63108 in Saint Louis City. The practice phone is (314) 652-0100.

  • Novus Health Inc
    3960 Lindell Blvd, Saint Louis, MO 63108 · Saint Louis CityPhone(314) 652-0100

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Mark Alan Scheperle is affiliated with 9 sites of care and 2 medical groups

Dr. Scheperle's primary practice is Novus Health Inc in Saint Louis, Missouri. Dr. Scheperle is also affiliated with Barnes-Jewish Hospital. The medical group on file is NOVUS Health. Dmand AI also links Dr. Scheperle to 5 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 11 affiliations for Dr. Scheperle

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Mark Alan Scheperle's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scheperle practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Novus Health IncAvailable with a free account
+8 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Scheperle practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark Alan Scheperle is one of 2,114 internists in Missouri

Internal medicine is Dr. Scheperle's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Scheperle's licenses on file in 2 states: Missouri and Illinois.

Specialties and state licenses

  • Internal medicine, MissouriPrimaryLicense R8N98 · 1990 to 2026 · taxonomy 207R00000X
  • Illinois license1995 to 2011

Clinical focus

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, aneurysm, anxiety, arteritis, arthritis and atrial fibrillation and flutter among the conditions Dr. Scheperle treats.

Internists near Dr. Scheperle

Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark Alan Scheperle billed Medicare for 804 services in 2024

CMS data shows 804 Medicare services from Dr. Scheperle across 6 procedure codes in 2024, for 250 Medicare patients. Medicare paid $54,325 for them. Every service was in an office.

Medicare services, 2024804
Medicare patients250
Paid by Medicare$54,325
Procedure codes6

Dr. Scheperle's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7252024: 60217%
Other services
2023: 1232024: 20264%
Drugs given in the office
2023: 172024: 0100%
Tests and treatments
2023: 252024: 0100%

Dr. Scheperle compared with the Missouri median for internists, 2024

  • Dr. Scheperle
  • Missouri median
Medicare services
804vs 53052% above
Medicare patients
250vs 21118% above
Part D claims
9,177vs 32528.2 times

Medians across 2,076 internists in Missouri with Dmand AI profiles that report each measure.

Dr. Scheperle's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Scheperle

Need commercial claims for Dr. Scheperle?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Scheperle and other internists in Missouri.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark Alan Scheperle treated 250 Medicare patients in 2024, average age 70

CMS counts 250 Medicare patients who saw Dr. Scheperle in 2024. The largest group is 65 to 74, with 125 patients. 64% of them have high blood pressure, and 51% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Scheperle's median patient age at 59, with 42% women.

Medicare patients, 2024250
Average age70
Average risk score1.10
Also on Medicaid16%

Dr. Scheperle's Medicare patients by age, 2024

Dr. Scheperle's Medicare patients by sex, 2024

  • Women10642%
  • Men14458%

Chronic conditions among Dr. Scheperle's Medicare patients, 2024

  1. High blood pressure64%
  2. High cholesterol51%
  3. Arthritis49%
  4. Anxiety26%
  5. Mood disorders26%
  6. Depression23%
  7. Diabetes21%
  8. Ischemic heart disease18%

Share of Medicare patients with each condition. A patient can have several.

Dr. Scheperle's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women42%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark Alan Scheperle wrote 10,174 Medicare Part D claims in 2024

In 2024, Dr. Scheperle wrote 10,174 Medicare Part D claims for 642 patients. 82% of them were for generic drugs. CMS names the drug for 9,177 of them, across 185 drugs with 11 or more claims each, at $3,897,980 in total drug cost. In 2023, CMS named 9,203 claims across 188 drugs.

Part D claims, 202410,174
Drugs named by CMS185
Total drug cost$3.9M
Part D patients642

Dr. Scheperle's Part D claims by kind of drug, 2024

  • Generic8,360 claims82%
  • Brand-name1,760 claims17%
  • Other54 claims1%

Dr. Scheperle's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Scheperle's Part D claims, 2024

  • Opioids14%1,392 of 10,174 claims
  • Antibiotics2%249 of 10,174 claims
  • Antipsychotics, patients 65 and over0%25 of 10,174 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9,2032024: 9,177No change

Drugs named by CMS: 185 in 2024, 188 in 2023.

See all prescribing by Dr. Scheperle

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark Alan Scheperle scored 79 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Scheperle for performance year 2024, reported individually. Dr. Scheperle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Scheperle's MIPS scores, performance year 2024

  • 79of 100Final score
  • 77.3of 100Quality
  • 40of 100Improvement Activities
  • 59of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find internists like Dr. Scheperle by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark Alan Scheperle received $136,261 in industry payments from 2016 to 2025

CMS Open Payments shows 2,237 general payments to Dr. Scheperle from 107 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Gilead Sciences, Inc. paid the most, $74,892.

General payments to Dr. Scheperle by program year, 2016 to 2025

General payments to Dr. Scheperle by kind, 2016 to 2025

$136.3Kin total
  • Speaker and faculty fees$81,91760%
  • Food and beverage$33,78725%
  • Travel and lodging$11,4218%
  • Consulting fees$5,2304%
  • Other$3,1042%

Companies that paid Dr. Scheperle the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Scheperle

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark Alan Scheperle graduated from UMKC School of Medicine

Dr. Scheperle graduated from UMKC School of Medicine in 1989.

  1. Medical schoolUMKC School of Medicine

Source: Dmand AI Professional Profile Data

Dr. Mark Alan Scheperle accepts plans from 19 insurance carriers

Dr. Scheperle is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Elevance
  • HCSC
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Humana
  • +11 more carriersWith a free account

Plan types Dr. Scheperle accepts, by number of carriers

  1. PPO13
  2. Medicare9
  3. HMO7
  4. EPO4
  5. POS4

Source: Dmand AI Insurance Network Data

Sources for Dr. Mark Alan Scheperle's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark Alan Scheperle

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark Alan Scheperle's NPI number?

Dr. Mark Alan Scheperle's NPI number is 1265417034. It was assigned on December 14, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark Alan Scheperle?

Dr. Mark Alan Scheperle is an internist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).

Where does Dr. Mark Alan Scheperle practice?

Dr. Scheperle practices at 3960 Lindell Blvd, Saint Louis, MO 63108. Dr. Scheperle's primary practice is Novus Health Inc in Saint Louis, Missouri. Dmand AI also links Dr. Scheperle to 5 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. Mark Alan Scheperle's office phone number?

The practice phone on file for Dr. Scheperle is (314) 652-0100.

What is Dr. Mark Alan Scheperle's medical license number?

Dr. Scheperle holds Missouri license R8N98, one of the licenses on file in 2 states.

Which states has Dr. Mark Alan Scheperle been licensed in?

Dmand AI has state licenses on file for Dr. Scheperle in Missouri (1990 to 2026) and Illinois (1995 to 2011).

Which hospitals is Dr. Mark Alan Scheperle affiliated with?

Dr. Scheperle is affiliated with Barnes-Jewish Hospital. Dmand AI links Dr. Scheperle to 5 more hospitals.

What medical group is Dr. Mark Alan Scheperle part of?

Dr. Scheperle is linked to NOVUS Health. Dmand AI links Dr. Scheperle to 1 more medical group.

Does Dr. Mark Alan Scheperle accept Medicare?

Yes. CMS data shows Dr. Scheperle billed Medicare for 804 services in 2024, and Dr. Scheperle accepts Medicare assignment.

What is Dr. Mark Alan Scheperle's MIPS score?

Dr. Scheperle's MIPS final score for performance year 2024 is 79 out of 100, reported individually.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Mark Alan Scheperle see?

CMS counts 250 Medicare patients who saw Dr. Scheperle in 2024, with an average age of 70.

What services does Dr. Mark Alan Scheperle bill to Medicare?

In 2024, Dr. Scheperle's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and medicare service (G0439).

Where did Dr. Mark Alan Scheperle go to medical school?

Dr. Scheperle graduated from UMKC School of Medicine in 1989.

What drugs does Dr. Mark Alan Scheperle prescribe most?

In 2024 Medicare Part D data, Dr. Scheperle's most prescribed drugs by claims were Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen and Amlodipine Besylate.

Has Dr. Mark Alan Scheperle received payments from drug or device companies?

CMS Open Payments shows $136,261 in general payments to Dr. Scheperle from 107 companies from 2016 to 2025. The largest total came from Gilead Sciences, Inc.

How long has Dr. Mark Alan Scheperle been practicing?

Dr. Scheperle graduated from medical school in 1989, 37 years ago.

What insurance does Dr. Mark Alan Scheperle accept?

Dr. Scheperle is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Selling to internal medicine practices?

See internists in Missouri by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)